Cancer Drug Resistance
All Journals
Search
Log In
Editor-in-Chief:
Godefridus J. Peters
Indexing:
ESCI
,
PMC
,
Scopus
,
CAS
,
CNKI
,
Dimensions
,
Lens
,
Embase
,
Journal Rank:
Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision:
63 days
Journal Flyer
Hot Keywords
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Home
About
About the Journal
Aims and Scope
Editorial Policies
Editorial Board
Junior Editorial Board
News
Journal History
Partners
Advertise
Contact Us
Publish with us
For Authors
Author Instructions
Article Processing Charges
Editorial Process
Manuscript Templates
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Articles
All Articles
Articles with Video Abstracts
Video Abstract Guidelines
Articles Ebooks
Special Issues
All Special Issues
Ongoing Special Issues
Completed Special Issues
Closed Special Issue
Special Issue Ebooks
Special Issue Guidelines
Special Collections
Volumes
Pre-onlines
Features
Webinars
Academic Talks
Interviews
Home
Articles
Special Issues
Volumes
Webinars
Videos
Menu
Cancer Drug Resistance
Search
Submit
Editor-in-Chief:
Godefridus J. Peters
Journal Rank:
Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision:
63 days
Home
Articles
Special Issues
Volumes
Webinars
Videos
Menu
Home
Features
Interviews
Interviews
Interview with Prof. David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment
Published on: 6 Nov 2024
Viewed:
Special Interview with Dr. Zhiqing Huang, Editorial Board Member of
Cancer Drug Resistance
Published on: 20 Feb 2023
Viewed:
Special Interview with Dr. Justin M. Balko
Published on: 19 Dec 2022
Viewed:
Special Interview with Prof. Wafik S. El-Deiry
Published on: 4 Apr 2023
Viewed:
Special Interview with Prof. John F. Seymour
Published on: 7 Dec 2022
Viewed:
Special Interview with Prof. Arrigo De Benedetti
Published on: 25 Nov 2022
Viewed:
Special Interview with Prof. Simo Schwartz Jr
Published on: 3 Nov 2022
Viewed:
The Discussion Between Prof. Masakazu Toi and Dr. Ravi Velaga on Breast Cancer
Published on: 8 Sep 2022
Viewed:
Special Interview with Prof. Jacqueline Cloos
Published on: 22 Aug 2022
Viewed:
Special Interview with Prof. Marina Y. Konopleva
Published on: 17 Aug 2022
Viewed:
Exclusive Interview with Prof. Guru P. Sonpavde - Guest Editor of the Special Issue
Published on: 15 Jul 2022
Viewed:
Cancer Drug Resistance
ISSN 2578-532X (Online)
editorial@cdrjournal.com
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Twitter
WeChat
Navigation
Contact Us
Sitemap
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/